Evidence map›Paper›PMID 36389100›Full record

ArticleClinicoEconomics and outcomes research : CEOR2022

Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis.

Wenzhen Ge, Degang Wang, Chien-Chia Chuang, Yongtao Li, Raj Rout, Shahid Siddiqui, Siddhesh Kamat

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in ClinicoEconomics and outcomes research : CEOR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Complications in Endoscopic Sinus Surgery: A TriNetX Network Analysis.International forum of allergy & rhinology · 2025
    Article
  3. The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Wenzhen GeHealth Economics and Outcomes Research, Medical Affairs, Regeneron, Tarrytown, NY, USA.
Degang WangHealth Economics and Outcomes Research, Medical Affairs, Regeneron, Tarrytown, NY, USA.
Chien-Chia ChuangGlobal Health Economics and Value Assessment, Sanofi, Cambridge, MA, USA.
Yongtao LiGlobal Medical Affairs, Sanofi, Bridgewater, NJ, USA.
Raj RoutGlobal Medical Affairs, Sanofi, Reading, UK.
Shahid SiddiquiHealth Economics and Outcomes Research, Medical Affairs, Regeneron, Tarrytown, NY, USA.
Siddhesh KamatHealth Economics and Outcomes Research, Medical Affairs, Regeneron, Tarrytown, NY, USA.ORCID 0000-0001-5205-9184
Regeneron (United States) · USSanofi (United States) · USSanofi (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Endoscopic nasal polyp (NP) surgery is a treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Previous studies report NP surgery costs of $8000-13,000 and risk of major complications of NP surgery of ~0.1-1%. Limited contemporary data for costs and complications associated with NP surgery in US clinical practice are available. Methods: IQVIA PharMetrics Plus claims data were used to identify patients with NP surgery in 2019 with ≥3 years continuous baseline health-plan enrollment prior to index date (date of first eligible NP surgery) and ≥30 days continuous enrollment after index (follow-up). In this descriptive analysis, total costs of NP surgery were estimated as all medical costs on the index date (or during the entire hospital stay for patients who received surgery in the inpatient setting). Total medical costs (all-cause) were estimated for all medical services occurring from the index date to the index date +9 or +29 days (10-day and 30-day). Major complication was defined as cerebrospinal fluid (CSF) leak, orbital injury, or major hemorrhage within 30 days of index. Results: Of 6311 patients, median age was 46 years (interquartile range: 34-56); 59.7% were male; 88.2% had no NP surgery in the prior 3 years; 63.7% had allergic rhinitis, and 37.1% had asthma. Mean (SD) total medical cost of surgery was $14,697 (11,679) and mean (SD) 10-day total medical cost was $15,401 (11,968). Major complications occurred in 102 (1.7%) patients. Total medical costs and 10-day costs were higher in patients with major complications than those without ($23,605 [19,264] vs $15,251 [11,741]). Conclusion: In this descriptive analysis, NP surgery costs and rates of major surgical complications were updated using recent real-world data in the US. Results indicated that NP surgery complication rates were numerically higher than previously reported.

Indexed as

chronic rhinosinusitis with nasal polypscomplicationscostsnasal polyp surgeryreal-world

Identifiers

PMID36389100
PMCPMC9651015
OpenAlexW4308447888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.